Total return · dividends and splits
AVGO
NVDA
| SYMBOL | PRICE | CHANGE | 5Y % | PREV CLOSE | DIR | REGIME |
|---|---|---|---|---|---|---|
| AVGOBroadcom Inc. | $357.90 | —+0.21% | +692.11% | — | SELL | RECOVERY |
| NVDANVIDIA Corporation | $230.36 | —+0.84% | +919.88% | — | BUY | BULL |
DRAWDOWN · THIS RANGE
| SYMBOL | CURRENT | PEAK | WORST | TROUGH |
|---|---|---|---|---|
| AVGO | -25.56% | 2026-06-02 | -41.15% | 2025-04-04 |
| NVDA | -2.17% | 2026-05-14 | -66.33% | 2022-10-14 |
PERIODS · 5Y BOOK
| SYMBOL | 1Y | 2Y | 3Y | 5Y |
|---|---|---|---|---|
| AVGO | - | - | - | - |
| NVDA | - | - | - | - |
ANNUAL · 5Y BOOK
| YEAR | AVGO | NVDA |
|---|---|---|
| - | - | - |
Compare FAQ
- What does the AVGO vs NVDA overlay show?
- LOPJLB overlays AVGO vs NVDA as total return (dividends and splits) from the first adjusted close in the selected 5Y window. Each path starts at 0% so you can read relative holding performance, not raw tape price.
- Is this holding return or tape close?
- Holding return. The series uses split- and dividend-adjusted close (Yahoo-style backward adjustment) when dividend coverage is sufficient, otherwise it falls back to tape close. Candles and technical overlays on /chart stay tape.
- Which windows are public?
- Public visitors can share 1M, 3M, 6M, YTD, 1Y, and 5Y. MAX is Research+. Direction and regime in the table follow the desk ladder: SPY25 on Free, full book on Essential+.
- How do I read the drawdown, period, and annual tables?
- Drawdowns are current and worst peak-to-trough on the visible range. Periods are calendar lookbacks (1Y / 2Y / 3Y / 5Y, plus 10Y on MAX) from the last bar. Annual is calendar-year holding return, with the latest year labeled YTD.
- How has AVGO vs NVDA performed on a normalized basis?
- AVGO vs NVDA holding-return overlay: 5Y AVGO +692.11% · NVDA +919.88%; worst drawdown AVGO -41.15% · NVDA -66.33%; YTD AVGO +3.34% · NVDA +22.13%. Numbers update from the live compare-series book.
- Is ticker compare investment advice?
- No. The overlay is research context only — not a recommendation to buy or sell any security.
Related: AVGO, NVDA, methodology, chart